4//SEC Filing
SAHNI PAYAL 4
Accession 0001225208-23-002988
CIK 0000078003other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 5:53 PM ET
Size
12.5 KB
Accession
0001225208-23-002988
Insider Transaction Report
Form 4
PFIZER INCPFE
SAHNI PAYAL
Executive Vice President
Transactions
- Exercise/Conversion
Common Stock
2023-02-25$22.89/sh+8,921$204,202→ 30,127 total - Tax Payment
Common Stock
2023-02-25$41.75/sh−1,786$74,566→ 28,341 total - Tax Payment
Common Stock
2023-02-25$43.44/sh−3,967$172,326→ 24,374 total - Tax Payment
Common Stock
2023-02-27$40.78/sh−1,297$52,892→ 23,077 total - Exercise/Conversion
Stock Appreciation Rights
2023-02-25−8,921→ 0 totalExercise: $22.89From: 2023-02-25Exp: 2023-02-25→ Common Stock (8,921 underlying)
Holdings
- 10,375(indirect: By Rule 16b-3 Plan)
Common Stock
Footnotes (6)
- [F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
- [F3]Price is the closing price of Pfizer common stock on February 24, 2023.
- [F4]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F5]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
- [F6]The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
Documents
Issuer
PFIZER INC
CIK 0000078003
Entity typeother
Related Parties
1- filerCIK 0001817124
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 5:53 PM ET
- Size
- 12.5 KB